Pharmacological aspects of withdrawal from certain benzodiazepines

Polish Journal of Pharmacology

Volumn 49, Issue 2-3, 1997, Pages 89-95

  Nowakowska, Elzbieta ^a   Chodera, Alfons ^a   Kus, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Benzodiazepine; Benzodiazepine receptor; Sedative and anxiolytic effect; Withdrawal

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CHLORDIAZEPOXIDE; FLUMAZENIL; FLUNITRAZEPAM;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; RECEPTOR DOWN REGULATION; SEDATION; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME;

ANIMALS; ANTIDOTES; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FLUMAZENIL; LOCOMOTION; MALE; RATS; RATS, WISTAR; RECEPTORS, GABA-A; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030841755     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Baldwin H. A., File S. E.: Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety. Psychopharmacology, 1989, 97, 424-426.
2. Braestrup C. M., Nielsen M., Nielsen E. B.: Benzodiazepine receptors in the brain as affected by different experimental stress: the changes are small and not undirectional. Psychopharmacology, 1979, 65, 273-277.
3. Crawley J. N.: Neuropharmacological specificity of a simple animal model for the behavioural actions of benzodiazepines. Pharmacol. Biochem. Behav., 1981, 15, 695-699.
4. De Blasi A., Cotecchia S., Mennini T.: Selective changes of receptor binding in brain regions of aged rats. Life Sci., 1982, 31, 335-340.
5. File S. E., Baldwin H. A.: Flumazenil: a possible treatment for benzodiazepine withdrawal anxiety. Lancet, 1987, 2, 106-107.
6. File S. E., Baldwin H. A.: Behavioural and biochemical aspects of benzodiazepine dependence in the rat. Psychopharmacology, 1988, 96, 89-92.
7. File S. E., Baldwin H. A., Aranko, K.: Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance. Brain Res. Bull., 1987, 19, 607-610.
8. File S. E., Pellow S.: Triazolobenzodiazepines antagonise the effects of anxiogenic drugs mediated at three different central nervous system sites. Neurosci. Lett., 1985, 61, 115-119.
9. File S. E., Pellow S.: Do the intrinsic actions of benzodiazepine receptor antagonists imply the existence of an endogenous ligand of the benzodiazepine receptor? In: Advances in Biochemical Pharmacology. GABA-ergic Transmission and Anxiety. Eds. Biggio G., Costa E., Raven Press, New York, 1986, 187-202.
10. Gallager D. W., Laskowski J. M., Gonsalves S. F., Raunch S. L.: Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature, 1984, 308, 74-77.
11. Geeler I., Kulak J. T., Seifter J.: The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination. Psychopharmacologia (Berlin), 1962, 3, 374-385.
12. Greenblatt D. J., Shader R. I.: Long-term administration of benzodiazepines: pharmacokinetic versus pharmacodynamic tolerance. Psychopharmacol. Bull., 1986, 22, 416-423.
13. Lader M.: The present status of benzodiazepines in psychiatry and medicine Arzneim.-Forsch.-Drug Res., 1989, 30, 910-915.
14. Lamb R. J., Griffiths R. R.: Effects of repeated Ro 15-1788 administration in benzodiazepine-dependent baboons. Eur. J. Pharmacol., 1985, 110, 257-261.
15. Lopez F.: Low-dose alprazolam augments motor activity in mice. Pharmacol. Behav., 1980, 30, 511-513.
16. Lowry O. A., Rosebrough A. D., Randall R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951, 193, 265.
17. Miller I. G., Greenblatt D. J., Barnhill J. G., Shader R. I.: Receptor down regulation is associated with tolerance to benzodiazepines. Clin. Res., 1987, 35, 579.
18. 3H] flunitrazepam binding to rat cerebellar and hippocampal membranes. Neuropharmacology, 1983, 22, 935-938.
19. O'Connor W. T., Earley B., Leonard G. E.: Antidepressant properties of the triazolobenzodiazepines alprazoam and adinazolam: studies in the olfactory bulbectomised rat model of depression. Brit. J. Clin. Pharmacol., 1985, 19, 45S-56S.
20. Peturrsson H., Lader M. H.: Withdrawal from longterm benzodiazepine treatment. Brit. Med. J., 1981, 283, 643-645.
21. Rastogi R. S., Lapierra Y. D., Singhal R. L.: Evidence for the role of brain norepinephrine and dopamine "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines. J. Psychiat. Res., 1976, 13, 65-75.
22. Ryan G. P., Boisse N. R.: Experimental induction of benzodiazepine tolerance and physical dependence. J. Pharmacol. Exp. Ther., 1983, 266, 100-106.
23. Schweizer E.: The pharmacological management of benzodiazepine withdrawal. Eur. Neuropsychopharmacol., 1996, Suppl. 3, 160.
24. 3H] flunitrazepam receptor binding in rats tolerant to the effects of nitrazepam. Eur. J. Pharmacol., 1988, 147, 7-11.
25. Treit D.: Evidence that tolerance develops to the anxiolytic effects of diazepam in rats. Pharmacol. Biochem, Behav., 1983, 22, 383-387.
26. Tyrer P., Owen R., Dawling S.: Gradual withdrawal of diazepam after long-term therapy. Lancet, 1983, 1, 1402-1406.
27. Vogel J. R., Beer B., Clody D. E.: A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia (Berlin), 1971, 21, 1-7.
28. Weber E.: Gründrisse der Biologischen Statistik, Jena, 1969.
29. Wilks L. J., File S. E.: Does the behavioural activation detected after a single dose of benzodiazepine reflect a withdrawal response? Life Sci., 1988, 42, 2349-2357.